Loading...
11 Oman Device Drug Combination Reports
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, Novo Nordisk, Medtronic, Eli Lilly and Company, Roche
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Medtronic, Roche, Novo Nordisk, Sanofi, Omnipod
Country Covered: Oman
Study Period: 2018 - 2030
Major Players: Novo Nordisk, Julphar, Novartis, Beckton Dickinson, Terumo
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, Medtronic, Roche, Dexcom, Novo Nordisk
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Beckton Dickinson, Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Julphar, Biocon, Sanofi, Eli Lilly and Company
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Medtronic, Dexcom, Abbott Laboratories, Roche
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Sanofi, Eli Lilly and Company, Medtronic, Roche
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, Medtronic, Eli Lilly and Company, Novo Nordisk, Roche
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Julphar